# Tayca Corporation, Okayama, Japan – FDA Inspections

Source: https://www.keypedia.com/companies/tayca-corporation/46216ddd-c2d8-492b-bbc2-7011e93a98bf

> Inspection records and compliance data for Tayca Corporation in Okayama. 5 FDA inspections on record, 2 Form 483s, last inspected August 25, 2023.

---

## Details

- Name: Tayca Corporation
- FEI Number: 3002777902
- Address Line 1: 1072 Nishikozai, Higashi;  Nishikozai;  Higashi; Nishikozai; Higashi
- City: Okayama
- Country Name: Japan
- Address: 1072 Nishikozai, Higashi;  Nishikozai;  Higashi; Nishikozai; Higashi, Okayama, Japan
- Country: Japan

## Related Documents

- [483 - Tayca Corporation - Unknown Date](https://www.keypedia.com/records/483/tayca-corporation/0e42c8a5-dac5-4a3e-ac69-f75748ddc0b7) — source: FDA, date: Invalid Date
- [483 - Tayca Corporation - 2023-08-25](https://www.keypedia.com/records/483/tayca-corporation/ac81e316-9d39-46c6-9709-909acd29e2ab) — source: FDA, date: August 25, 2023
- [FDA Inspection 1219130 - Tayca Corporation - 2023-08-25](https://www.keypedia.com/records/fda_inspections/tayca-corporation/6cd9ce85-bb7f-4a1a-9855-15ddab3b11ee) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 25, 2023
- [483 - Tayca Corporation - 2017-12-15](https://www.keypedia.com/records/483/tayca-corporation/5faaae5f-1f1b-48bc-b338-a070ad45ad48) — source: FDA, date: December 15, 2017
- [FDA Inspection 1038594 - Tayca Corporation - 2017-12-15](https://www.keypedia.com/records/fda_inspections/tayca-corporation/4946f71a-6848-47ff-8d8d-64ca1532a937) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 15, 2017
- FDA Inspection 989845 - Tayca Corporation - 2016-09-09 — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 9, 2016
- FDA Inspection 855688 - Tayca Corporation - 2013-11-08 — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 8, 2013
- FDA Inspection 615187 - Tayca Corporation - 2009-08-27 — classification: No Action Indicated (NAI), source: FDA, date: August 27, 2009

## Related Companies

- [Cdymax (India) Pharma Private Limited](https://www.keypedia.com/companies/cdymax-india-pharma-private-limited/51bc8d84-9900-43c0-8e1c-9d2bd08b0ac4)
- [Hetero Drugs Ltd. - Unit 1](https://www.keypedia.com/companies/hetero-drugs-ltd-unit-1/4c15935a-9ff7-4f66-b649-3d78aa3e9753)
- [Hetero Labs Limited](https://www.keypedia.com/companies/hetero-labs-limited/511d3250-3361-4a46-af69-a80476303c91)
- [Corden Pharma Colorado, Inc.](https://www.keypedia.com/companies/corden-pharma-colorado-inc/d47254de-6718-4960-b0eb-0768d896cdc0)
- [International Chemical Entity Japan Co., Ltd.](https://www.keypedia.com/companies/international-chemical-entity-japan-co-ltd/2df2ae11-1140-4d29-86fd-eecb26da4bd9)
- [Linhai Tianyu Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/linhai-tianyu-pharmaceutical-co-ltd/0ec07318-0eee-4a4c-84a5-1bbd812ebfcf)
- [Zhuhai Rundu Pharmaceutical Co Ltd](https://www.keypedia.com/companies/zhuhai-rundu-pharmaceutical-co-ltd/41358c8c-249a-4cdb-bb26-259ff492823f)
- [Shandong Luxi Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/shandong-luxi-pharmaceutical-co-ltd/d676adc9-409f-4ea4-881b-d2cf1ab1e684)
- [Goodwin Biotechnology, Inc.](https://www.keypedia.com/companies/goodwin-biotechnology-inc/ecf6d534-aaa3-4d43-b900-12cc1172cc90)
- [Ajinomoto Health & Nutrition North America, Inc.](https://www.keypedia.com/companies/ajinomoto-health-nutrition-north-america-inc/b9d2156b-cff2-47e8-8519-5f63178995d2)

## Related Officers

- [Investigator](https://www.keypedia.com/people/marcellinus-d-dordunoo/a0e35c24-0cf5-4b11-95ba-1693fa3ecb3a)
- [Pharmacy Compounding National Expert, Drug Specialist, Drug Specialist, Foreign Cadre](https://www.keypedia.com/people/jessica-l-pressley/2c190e50-81bd-4015-95f0-7177beb363bd)
- [issuing_officer](https://www.keypedia.com/people/gavin-t-cua/6f498dd6-2c4b-42e9-8ddc-3c2a7c97afef)